Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit from intensified treatment. It is important to target intensified therapy ...
Prostate cancer is a leading cause of cancer-related death among men in the United States. Despite this, widespread adoption of prostate cancer screening has been controversial. Many primary care ...
Pre-biopsy MRIs can help doctors diagnose and treat prostate cancer more accurately. Here’s when you should get one.
MyTwinTiers.com on MSN
What’s the guidance on prostate cancer screening? It’s complicated.
Former President Joe Biden's prostate cancer diagnosis is highlighting the importance of screening for one of the most common ...
Up to 5,000 men every year could be facing unnecessary overtreatment for prostate cancer due to ‘outdated’ guidelines, a charity has warned. Overtreatment of the disease can lead to side effects such ...
Hosted on MSN
Prostate cancer patients could avoid overtreatment if NICE updated its guidelines, charity says
Up to 5,000 men a year could avoid potentially harmful treatment for prostate cancer if ‘outdated’ guidelines reflected the latest evidence, a charity has said. Closely monitoring the disease with ...
After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels. Persistently elevated PSA levels indicate residual cancer and are linked to ...
Risk factors like Gleason score, cancer stage, PSA levels, and genetic markers guide prostate cancer treatment decisions. Treatment options include active surveillance, surgery, radiation, hormone ...
In cases of clinical equipoise, the highest MMAI score quartile could guide selective treatment intensification among patients with high-risk nonmetastatic prostate cancer. An artificial ...
A new analysis indicates that many men with prostate cancer obtain second opinions from urologists before starting treatment, but surprisingly, second opinions are not associated with changes in ...
A multidisciplinary consortium of researchers and clinicians from 12 European countries and 25 institutions has launched PRAISE-U (PRostate cancer Awareness and Initiative for Screening in the ...
One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results